PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Studies on curative efficacy of monoterpene eugenol on anti-leukemic drug arsenic trioxide induced cardiotoxicity.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28494415 ↗2017Reported benefit

Studies on curative efficacy of monoterpene eugenol on anti-leukemic drug arsenic trioxide induced cardiotoxicity.

RatChemical/toxinWistarMale5 mg/kg body weightGiven as combination treatment with arsenic trioxide

Model: Arsenic trioxide-induced cardiotoxicity, arsenic trioxide 4 mg/kg body weight

Eugenol maintained tissue antioxidant levels and ATPase activity, normalised cytosolic ion levels, reduced membrane peroxidation, restored heart rate and corrected QT prolongation, with histology supporting protection against arsenic-induced oxidative damage.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.